Graham Capital Management’s Twist Bioscience TWST Stock Holding History

Graham Capital Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,554	Closed	-$264K	–	1517
2026 Q1	$264K	Buy	+5,554	New	+$249K	0.01%	868
2025 Q3	–	Sell	-53,911	Closed	-$1.98M	–	1656
2025 Q2	$1.98M	Buy	53,911 +30,376	+129%	+$1.05M	0.03%	360
2025 Q1	$924K	Buy	23,535 +6,107	+35%	+$275K	0.02%	577
2024 Q4	$810K	Buy	17,428 +3,483	+25%	+$157K	0.01%	556
2024 Q3	$630K	Sell	13,945 -69	-0.5%	-$3.28K	0.01%	578
2024 Q2	$691K	Sell	14,014 -8,249	-37%	-$336K	0.02%	491
2024 Q1	$764K	Buy	22,263 +6,645	+43%	+$240K	0.01%	495
2023 Q4	$576K	Buy	15,618 +603	+4%	+$13.9K	0.01%	555
2023 Q3	$304K	Buy	+15,015	New	+$330K	0.01%	718
2020 Q4	–	Sell	-14,748	Closed	-$1.12M	–	128
2020 Q3	$1.12M	Sell	14,748 -23,313	-61%	-$1.45M	0.04%	80
2020 Q2	$1.72M	Buy	+38,061	New	+$1.37M	0.08%	70

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Graham Capital Management's TWST Position: Q2 2026 in Review

Graham Capital Management sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 5,554 shares — an estimated $264K sold.

Graham Capital Management first reported a position in TWST in Q2 2020 and held it in 11 quarters. The position peaked at $1.98M in Q2 2025. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Graham Capital Management reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
Graham Capital Management sold 5,554 Twist Bioscience shares in Q2 2026, an estimated $264K.
Graham Capital Management first reported a position in Twist Bioscience in Q2 2020 and held it in 11 quarters.
Graham Capital Management's Twist Bioscience position peaked at $1.98M in Q2 2025.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.